Literature DB >> 27436841

Vehicle effects on human stratum corneum absorption and skin penetration.

Alissa Zhang1, Eui-Chang Jung2, Hanjiang Zhu2, Ying Zou3, Xiaoying Hui2, Howard Maibach2.   

Abstract

This study evaluated the effects of three vehicles-ethanol (EtOH), isopropyl alcohol (IPA), and isopropyl myristate (IPM)-on stratum corneum (SC) absorption and diffusion of the [14C]-model compounds benzoic acid and butenafine hydrochloride to better understand the transport pathways of chemicals passing through and resident in SC. Following application of topical formulations to human dermatomed skin for 30 min, penetration flux was observed for 24 h post dosing, using an in vitro flow-through skin diffusion system. Skin absorption and penetration was compared to the chemical-SC (intact, delipidized, or SC lipid film) binding levels. A significant vehicle effect was observed for chemical skin penetration and SC absorption. IPA resulted in the greatest levels of intact SC/SC lipid absorption, skin penetration, and total skin absorption/penetration of benzoic acid, followed by IPM and EtOH, respectively. For intact SC absorption and total skin absorption/penetration of butenafine, the vehicle that demonstrated the highest level of sorption/penetration was EtOH, followed by IPA and IPM, respectively. The percent doses of butenafine that were absorbed in SC lipid film and penetrated through skin in 24 h were greatest for IPA, followed by EtOH and IPM, respectively. The vehicle effect was consistent between intact SC absorption and total chemical skin absorption and penetration, as well as SC lipid absorption and chemical penetration through skin, suggesting intercellular transport as a main pathway of skin penetration for model chemicals. These results suggest the potential to predict vehicle effects on skin permeability with simple SC absorption assays. As decontamination was applied 30 min after chemical exposure, significant vehicle effects on chemical SC partitioning and percutaneous penetration also suggest that skin decontamination efficiency is vehicle dependent, and an effective decontamination method should act on chemical solutes in the lipid domain.

Entities:  

Keywords:  Vehicle effect; percutaneous absorption; skin barrier; skin reservoir; stratum corneum

Mesh:

Substances:

Year:  2016        PMID: 27436841     DOI: 10.1177/0748233716656119

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  5 in total

1.  The effect of alcohols as vehicles on the percutaneous absorption and skin retention of ibuprofen modified with l-valine alkyl esters.

Authors:  Paula Ossowicz; Joanna Klebeko; Ewa Janus; Anna Nowak; Wiktoria Duchnik; Łukasz Kucharski; Adam Klimowicz
Journal:  RSC Adv       Date:  2020-11-16       Impact factor: 4.036

2.  Skin Irritation Testing beyond Tissue Viability: Fucoxanthin Effects on Inflammation, Homeostasis, and Metabolism.

Authors:  Renata Spagolla Napoleão Tavares; Silvya Stuchi Maria-Engler; Pio Colepicolo; Hosana Maria Debonsi; Monika Schäfer-Korting; Uwe Marx; Lorena Rigo Gaspar; Christian Zoschke
Journal:  Pharmaceutics       Date:  2020-02-05       Impact factor: 6.321

3.  The Influence of Oily Vehicle Composition and Vehicle-Membrane Interactions on the Diffusion of Model Permeants across Barrier Membranes.

Authors:  Omaima N Najib; Gary P Martin; Stewart B Kirton; Michelle J Botha; Al-Sayed Sallam; Darragh Murnane
Journal:  Membranes (Basel)       Date:  2021-01-14

4.  Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters.

Authors:  Ewa Janus; Paula Ossowicz; Joanna Klebeko; Anna Nowak; Wiktoria Duchnik; Łukasz Kucharski; Adam Klimowicz
Journal:  RSC Adv       Date:  2020-02-21       Impact factor: 4.036

5.  Enhancement strategies for transdermal drug delivery systems: current trends and applications.

Authors:  Delly Ramadon; Maeliosa T C McCrudden; Aaron J Courtenay; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2021-01-20       Impact factor: 4.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.